Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04825353
Other study ID # IDIRB2017122601-268
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 20, 2019
Est. completion date November 1, 2022

Study information

Verified date July 2022
Source Benha University
Contact Waleed El-Shaer, M.D
Phone 01015767331
Email waleed_elshaer@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

currently, percutaneous nephrolithotomy (PCNL) is the standard procedure of choice for management of large renal more than 2 cm. the pivotal step in performing PCNL is creation of proper tract. this step can be done monitored under guidance of different modalities such as fluoroscopy, ultrasonography, endoscopy or combined in ECIRS, tract creation is controlled under endoscopic vision with a flexible ureteroscope .


Description:

Aim: compare safety and efficacy and adverse events of ECIRS in comparison of standard fluoroscopic guided PCNL. patients & methods: Patients will randomly be divided into two equal groups: Group A: Patient will undergo ECIRS. Group B: Patient will undergo standard PCNL


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date November 1, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - patients with renal stones diameter of at least 2 cm. - American Society of Anesthesiology score = 2. Exclusion Criteria: - patients with renal anomalies. - transplanted kidney. - uncorrected coagulopathy. - active infection.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Endoscopic compbined guided PCNL
patient undergo stone removal by ECIRS
Standard PCNL
patient undergo SPCNL

Locations

Country Name City State
Egypt Banha university hospital Banha Qalubia

Sponsors (1)

Lead Sponsor Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stone Free Rate If their is any residual stones 1day after operation.
Primary Stone Free Rate If their is any residual stones 1 months post operative
Primary Stone Free Rate If their is any residual stones 3 months post-operative
Secondary operative time the length of operation intra oprative
Secondary blood loss hemoglobin drop pre-operative and 1 day post-oprative
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03243682 - The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones N/A
Active, not recruiting NCT04643145 - Optimal Drainage After Flexible Ureterorenoscopy; Prospective Assessment of Perioperative Outcomes and Health-Related Quality of Life Through a Randomized Controlled Trial N/A
Not yet recruiting NCT05299996 - Flexible URS in Management of Renal Stones in Anomalous Kidney N/A